Mechanism and Dosimetry Exploration in TES Magnetic Resonance Current Mapping Methods
NCT ID: NCT03772210
Last Updated: 2022-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
123 participants
INTERVENTIONAL
2019-01-03
2022-06-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Temporal Interference Methods for Non-invasive Deep Brain Stimulation, Study 1.1
NCT07215299
Temporal Interference Methods for Non-invasive Deep Brain Stimulation, Study 1.2
NCT07339072
TMS With Real-time E-field and EEG Source Imaging
NCT06645613
MRI Study of Noninvasive Transcranial Electrical Stimulation in Tinnitus
NCT03544359
Probing Cortical Excitability and Cognitive Function With TMS
NCT03652012
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In tACS, it has been found that at low frequencies (up to 80 Hz) tACS excitation frequencies may entrain neural networks with excitatory or inhibitory effects that depend on the frequency chosen, the current intensity and the phase of current application relative to underlying EEG rhythms.
Intersubject variability has been reported in both tDCS and tACS, and study reproducibility has been problematic. Apart from factors relating to the subject initial state, individual neuroanatomy and differences in cerebrospinal fluid volume, it has also been suggested that major contributions to variability between individual sessions of a study or may be inconsistencies in electrode application protocol. In particular, overuse of saline contact medium can result in the effective electrode area increasing beyond the electrode face, and if fastening straps are thinner than electrodes, contact area may be reduced. Electrodes may also move during sessions, or be placed inconsistently on different subjects. Between sites, reproducibility may be degraded because electrode shapes, types and placements are not consistent.
Knowledge of the exact distribution formed within the brain by the externally applied currents would clarify many study outcomes and most importantly allow more precise explorations of mechanism. Further, the effects of different current application protocols, electrode designs and study procedures could easily be resolved. Thus, a method for measuring current distributions formed by tDCS or tACS would answer many questions in this active field.
In the absence of methods for easily measuring or imaging current flow distributions, computational models have been used extensively to predict flow patterns. A large literature exists using computational models to explore effects of different montages, electrode areas and geometries on voltage distributions, electric fields or current flow. Increasingly sophisticated approaches have been devised to model the head subject to tDCS stimulation. As the field has grown, head model complexity has increased from spherical uniform, spherical four-compartment, realistic geometry, to high-resolution anisotropic models of the human head subject to electrical stimulation. This last category has involved merging source images based on MR images with diffusion-weighted images of the subject to predict white matter conductivity tensors. One approach to this uses water translational diffusion tensor eigenvectors to determine the direction of the conductivity tensor (assuming they are co-aligned) in combination with literature values of white matter conductivities. Another approach involves direct scaling of the white matter diffusion tensor to conductivity values. Most other model tissue conductivities are chosen from values measured on bulk tissues in the literature. However, to date no validation of these models has been possible in human subjects.
Some efforts have been made to measure current distributions resulting from tDCS. In a recent paper, Opitz et al. measured electric field distributions caused by transcranial stimulation via electrodes placed in a bilateral montage (left and right temples) using electrode arrays placed near the cortical surface of patients being monitored to identify epilepsy seizure foci. tACS was applied at 1-15 Hz with an intensity of 1 mA, and maximum electrical field strengths of 0.36 and 0.16 mV/mm were identified. A slight frequency dependent increase in conductivity (ca. 10%) was observed, and little capacitive effect. Again, these field strengths would not normally be sufficient to cause direct tissue stimulation, and support theories that slight depolarizations may be responsible for tDCS effects.
Researchers seeking to understand tES mechanisms have initiated fMRI studies to investigate the correlation of therapeutic current administration and brain activity as evidenced by changes in the BOLD contrast18-20. In the course of this research it has been noted that current administration creates artifacts on MR images. In another paper, fMRI analysis methods were used to find voxel clusters correlating with current flow features22. However, to date, there have been no attempts to non-invasively image tDCS or tACS current density distributions in humans directly.
The technique of Current Density Imaging (CDI) as suggested by Scott et al. (1991) is a method for translating the phase part of magnetic resonance images into individual magnetic flux density vector components caused by an externally applied current flow. These measurements can then be used to compute current density distributions using Ampere's law. The basic CDI technique requires the external current to be injected into subjects in concert with a sequence of RF pulses and gradient fields used to create MR images. The technique was demonstrated in phantoms and used to image current flow in a rabbit brain. Unfortunately, it is infeasible in humans because of the need to rotate the subject twice inside the scanner bore in order to obtain all three components of the magnetic flux density.
MR Electrical Impedance Tomography (MREIT) has been developed over the last decade as a method for imaging current density and conductivity distributions in the human body. As in CDI, MREIT requires current to be applied to a subject in conjunction with a particular MR sequence. However, MREIT methods make it possible to reconstruct conductivity, electric field and current density distributions in subjects by using only one component (Bz) of magnetic flux density vectors. A recently developed MREIT method, DT-MREIT, can be used to reconstruct full anisotropic conductivities and current density distributions using MREIT and DTI data gathered from the same subject, and has recently been demonstrated in canines.
In this work, the investigators will use MREIT methods to produce:
A. Quantitative physical measures demonstrating tES reproducibility, exploring effects of current intensity, sex and neuroanatomic differences on measured current distributions.
B. Comparisons of actual current density distributions developed in a target structure (DLPFC) with fMRI measures of activity.
These studies will provide the first tests of the assumptions that
* effects of tDCS stimulation are largest in the targeted region
* that the largest field and current flow is found in the targeted region These studies therefore have the potential to revolutionize understanding of tES mechanisms and practice.
This work has three aims, one focused on technical improvements in our present MREIT acquisition procedures, another targeted at quantifying replicability, measuring current flow distributions at different current intensities, and finally, in assessing correlations of electric field and current density distributions with brain activity measures using fMRI.
Specific Aim 1 (SA1) MREIT Pulse Sequence Acceleration and Improvements.
Specific Aim 2 (SA2) Replicability and Consistency in tDCS/tACS Protocols Current density distributions will be imaged in normal volunteers using an F3-F4 montage with three different current intensities, and repeat the measure at intervals of at least one week. Each time, the montage will be reapplied and subjects re-imaged. Both intra- and inter-subject variations in measured current and electric field distributions will be determined.
Specific Aim 3 (SA3) Correlation of functional measures with measured electrical distribution measures Participants' performance on a 2-back/0-back memory task will be compared in both Sham and Active subjects, using either 1, 1.5 or 2 mA intensity stimulation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
Participant performance on a 3-back/0-back memory task will be compared in both Sham and Active subjects, using either 1, 1.5 or 2 mA intensity stimulation.
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Current Intensity 1 mA
tDCS will be administered at an intensity of 1 mA to locations F3-F4, and fMRI response during performance of a 3-back/0-back memory task will be assessed.
tDCS
Current will be administered to subject groups as specified in arm descriptions.
Sham 1 mA
Determine fMRI response during performance of a 3-back/0-back memory task with sham 1 mA tDCS.
Sham
Apparent Stimulation administered
Current Intensity 1.5 mA
tDCS will be administered at an intensity of 1.5 mA to locations F3-F4, and fMRI response during performance of a 3-back/0-back memory task will be assessed.
tDCS
Current will be administered to subject groups as specified in arm descriptions.
Sham 1.5 mA
Determine fMRI response during performance of a 3-back/0-back memory task with sham 1.5 mA tDCS.
Sham
Apparent Stimulation administered
Current Intensity 2 mA
tDCS will be administered at an intensity of 2 mA to locations F3-F4, and fMRI response during performance of a 3-back/0-back memory task will be assessed.
tDCS
Current will be administered to subject groups as specified in arm descriptions.
Sham 2 mA
Determine fMRI response during performance of a 3-back/0-back memory task with sham 2 mA tDCS.
Sham
Apparent Stimulation administered
Structural, Diffusion and MREIT Imaging
Structural and High angular resolution diffusion weighted imaging will be performed.
Magnetic Resonance Electrical Impedance Tomography imaging will be performed using electrode locations F3-F4.
tDCS
Current will be administered to subject groups as specified in arm descriptions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tDCS
Current will be administered to subject groups as specified in arm descriptions.
Sham
Apparent Stimulation administered
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English as Native Language
Exclusion Criteria
* Pregnancy
* Subjects will not have any implanted or attached metallic devices.
* Appreciable deficits in hearing
* Appreciable problems with articulation
* Neuroanatomic abnormality
* Any neurological disorder associated with cognitive impairment.
* Any implanted cardiac pacemaker
* Dementia or Mini-Mental State Exam \<24
* Low estimated verbal intelligence per WTAR
* Active or Prior history of Seizure Disorder
* Family History of Seizure disorder
* Prescribed Seizure inducing medication
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Arizona State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rosalind J Sadleir, PhD
Role: PRINCIPAL_INVESTIGATOR
Arizona State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arizona State University
Tempe, Arizona, United States
University of Florida
Gainesville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00006012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.